Global Pharmatech, Inc. (GBLP)
USD 0.2
(-28.12%)
USD 0.2
(-28.12%)
| Breakdown | 2023 | 2022 | 2021 | 2007 | 2006 | 2005 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -199.26 Thousand | 391.44 Thousand | -62.63 Thousand | -383.93 Thousand | 261.77 Thousand | -1.86 Million |
| Net Income | -138.49 Thousand | -21 Thousand | -113.31 Thousand | -2.44 Million | -1.23 Million | 200.69 Thousand |
| Depreciation & Amortization | - | - | - | 416.2 Thousand | 538.84 Thousand | 530.17 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -60.76 Thousand | 412.44 Thousand | 50.67 Thousand | 371.41 Thousand | 397.88 Thousand | -2.51 Million |
| Other non-cash items | 18.51 Thousand | -75.49 Thousand | -676.00 | 1.65 Million | 1.44 Million | 2.94 Million |
| Investing Cash Flow | 22.68 Thousand | -228.57 Thousand | - | -198.54 Thousand | -389.92 Thousand | -381.32 Thousand |
| Investments in PPE | 199.26 Thousand | -228.57 Thousand | - | -191.85 Thousand | -414.95 Thousand | -381.32 Thousand |
| Acquisitions | 22.08 Thousand | - | - | - | 25.03 Thousand | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 600.44 | - | - | -6692.00 | - | - |
| Financing Cash Flow | 164.72 Thousand | -131.18 Thousand | 64.04 Thousand | 175.65 Thousand | 4.82 Million | 2.73 Million |
| Debt repayment | -30.41 Thousand | - | - | - | -200.25 Thousand | -1.22 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 118.59 Thousand | 340.49 Thousand | 64.13 Thousand | - | 4.62 Million | 1.26 Million |
| Other Financing Activities | 15.71 Thousand | -471.67 Thousand | -80.00 | 175.65 Thousand | - | 247.8 Thousand |
| Accounts receivables | -5046.89 | -136.77 Thousand | - | -29.87 Thousand | 690.78 Thousand | -1.69 Million |
| Accounts payables | -8906.99 | 235.63 Thousand | 676.00 | 287.18 Thousand | -151.6 Thousand | -217.46 Thousand |
| Inventory | -4559.64 | -23.36 Thousand | - | 195.92 Thousand | -342.16 Thousand | -48.57 Thousand |
| Other working capital | -42.25 Thousand | 336.95 Thousand | 50 Thousand | -81.82 Thousand | 200.86 Thousand | -556.09 Thousand |
| Cash at beginning of period | 33.1 Thousand | 1412.16 | 1.00 | - | - | - |
| Cash at end of period | 21.23 Thousand | 33.1 Thousand | 1412.00 | -406.82 Thousand | 4.69 Million | 490.66 Thousand |
| Capital Expenditure | 199.26 Thousand | -228.57 Thousand | - | -191.85 Thousand | -414.95 Thousand | -381.32 Thousand |
| Effect of forex changes on cash | - | -0.16 | - | - | - | - |
| Net cash flow / Change in cash | -11.86 Thousand | 31.68 Thousand | 1411.00 | -406.82 Thousand | 4.69 Million | 490.66 Thousand |
| Free Cash Flow | - | 162.87 Thousand | -62.63 Thousand | -575.79 Thousand | -153.17 Thousand | -2.24 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -32.76 Thousand | -9780.02 | -32.28 Thousand | -138.49 Thousand | -44.47 Thousand | -30.66 Thousand |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 43.9 Thousand | -6917.54 | -505.37 | -60.76 Thousand | -58.68 Thousand | -7880.23 |
| Other non-cash items | -48.13 Thousand | 3053.75 | 11.51 Thousand | 18.51 Thousand | 2968.97 | 4291.07 |
| Investing Cash Flow | 5405.42 | 5070.74 | 3290.43 | 22.68 Thousand | 4277.36 | 11.54 Thousand |
| Investments in PPE | -11.14 Thousand | -92.74 | 571.64 | - | - | -359.18 |
| Acquisitions | 5405.42 | 5163.48 | 3498.51 | 22.08 Thousand | 4198.40 | 10.96 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -779.72 | 600.44 | 78.96 | 942.02 |
| Financing Cash Flow | -2951.09 | 5800.81 | 19.93 Thousand | 164.72 Thousand | 107.69 Thousand | 28.34 Thousand |
| Debt repayment | - | - | -20.21 Thousand | -30.41 Thousand | - | -10.2 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 118.59 Thousand | 107.36 Thousand | - |
| Other Financing Activities | -2951.09 | 5800.81 | -275.72 | 15.71 Thousand | 334.94 | 18.14 Thousand |
| Accounts receivables | -56.48 Thousand | 3769.88 | -9146.41 | -5046.89 | -844.61 | 6793.21 |
| Accounts payables | 100 Thousand | -6870.62 | -378.72 | -8906.99 | 710.08 | -11.66 Thousand |
| Inventory | 4613.82 | 46.99 | -1988.00 | -4559.64 | -2834.44 | 578.66 |
| Other working capital | -4231.54 | -3863.79 | 11 Thousand | -42.25 Thousand | -55.71 Thousand | -3589.16 |
| Cash at beginning of period | 15.41 Thousand | 21.23 Thousand | 30.79 Thousand | 33.1 Thousand | 21.98 Thousand | 20.64 Thousand |
| Cash at end of period | 29.01 Thousand | 15.41 Thousand | 21.23 Thousand | 21.23 Thousand | 30.79 Thousand | 21.98 Thousand |
| Capital Expenditure | -11.14 Thousand | -92.74 | 571.64 | - | - | -359.18 |
| Effect of forex changes on cash | - | - | -0.43 | - | 0.62 | 0.15 |
| Net cash flow / Change in cash | 13.6 Thousand | -5826.00 | -9561.00 | -11.86 Thousand | 8809.00 | 1347.00 |
| Free Cash Flow | - | -16.78 Thousand | -32.21 Thousand | -199.26 Thousand | -103.16 Thousand | -38.9 Thousand |
DMCOF
APTK
CTMCF
CMPGF
ICCM
UNITEDTEA